Novavax’s Nuvaxovid ™ Receives Positive CHMP Opinion for Full Marketing Authorization for the Prevention of COVID in the EU
Nuvaxovid NVX-CoV2373 is a protein-based vaccine made by creating copies of the surface spike protein of SARS-CoV-2 that causes COVID.